Cna Financial Corp Insmed Inc Transaction History

Cna Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$20.88 - $28.21 $56,376 - $76,167	-2,700 Reduced 13.27%	17,644 $380,000
Q2 2022 Aug 09, 2022	SELL	$17.07 - $25.71 $21,337 - $32,137	-1,250 Reduced 5.79%	20,344 $401,000
Q4 2021 Feb 11, 2022	BUY	$25.89 - $33.45 $30,550 - $39,471	1,180 Added 5.78%	21,594 $588,000
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $24,032 - $31,532	1,070 Added 5.53%	20,414 $562,000
Q2 2021 Aug 12, 2021	BUY	$24.17 - $36.01 $32,629 - $48,613	1,350 Added 7.5%	19,344 $551,000
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $20,982 - $28,794	-650 Reduced 3.49%	17,994 $613,000
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $101,269 - $130,538	-3,220 Reduced 14.73%	18,644 $621,000
Q3 2020 Nov 12, 2020	BUY	$26.0 - $34.5 $112,840 - $149,730	4,340 Added 24.77%	21,864 $703,000
Q2 2020 Aug 13, 2020	BUY	$14.11 - $29.42 $247,263 - $515,556	17,524 New	17,524 $483,000

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.